For moderate to severe hypoglycemia due to diabetes, a prescription medication containing the hormone glucagon can be delivered by injection or nasal inhalation. Hypoglycemic emergencies, in which ...

The Food and Drug Administration (FDA) has expanded the approval of Baqsimi (glucagon) nasal powder to include the treatment of severe hypoglycemia in patients aged 1 year and older with diabetes.

The bills, which have advanced in the Senate, would require schools to take certain preventative measures to protect student ...

Nasal vestibulitis is an infection of the nostrils. This condition gets its name because it occurs in the nasal vestibule, the hair-covered area inside the nostrils. Nasal vestibulitis can be caused ...

The bills would mandate automated defibrillators on campus, require athletes to take an EKG and allow school nurses to ...

Clinical hold lifted for late stage cadisegliatin program for diabetes CATT1 Phase 3 trial in patients with type 1 diabetes (T1D) expected to resume Q2 2025 Strengthens commercial leadership with appo ...

Baqsimi is a nasal spray formulation of glucagon, already widely used as an injectable treatment for hypoglycaemia, which can occur when people with diabetes inadvertently take too much insulin.